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a b s t r a c t
Human hypothalamic hamartoma (HH) is a rare subcortical lesion associated with treatment-resistant epilepsy.
Cellular mechanisms responsible for epileptogenesis are unknown. We hypothesized that neuronal gap junctions
contribute to epileptogenesis through synchronous activity within the neuron networks in HH tissue. We studied
surgically resected HH tissue with Western-blot analysis, immunohistochemistry, electron microscopy, biocytin
microinjection of recorded HH neurons, and microelectrode patch clamp recordings with and without pharmacological blockade of gap junctions. Normal human hypothalamus tissue was used as a control. Western blots
showed increased expression of both connexin-36 (Cx36) and connexin-43 (Cx43) in HH tissue compared
with normal human mammillary body tissue. Immunohistochemistry demonstrated that Cx36 and Cx43 are
expressed in HH tissue, but Cx36 was mainly expressed within neuron clusters while Cx43 was mainly expressed
outside of neuron clusters. Gap-junction proﬁles were observed between small HH neurons with electron microscopy. Biocytin injection into single recorded small HH neurons showed labeling of adjacent neurons,
which was not observed in the presence of a neuronal gap-junction blocker, meﬂoquine. Microelectrode ﬁeld recordings from freshly resected HH slices demonstrated spontaneous ictal/interictal-like discharges in most slices.
Bath-application of gap-junction blockers signiﬁcantly reduced ictal/interictal-like discharges in a concentrationdependent manner, while not affecting the action-potential ﬁring of small gamma-aminobutyric acid (GABA)
neurons observed with whole-cell patch-clamp recordings from the same patient's HH tissue. These results suggest that neuronal gap junctions between small GABAergic HH neurons participate in the genesis of epileptic-like
discharges. Blockade of gap junctions may be a new therapeutic strategy for controlling seizure activity in HH
patients.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).

1. INTRODUCTION
Human hypothalamic hamartomas (HHs) are developmental
malformations occurring in the ventral hypothalamus. HHs are associated with neurological and endocrine disorders, including intractable seizures, cognitive impairment, behavioral disturbances, and central
precocious puberty (Berkovic et al., 1988; Kerrigan et al., 2005). The epileptic syndrome in HH patients is characterized by laughing (gelastic)
seizures, often beginning in early infancy. Most patients with gelastic
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seizures have a progressive natural history, and later develop additional
seizure types and cognitive and psychiatric comorbidities (Berkovic et
al., 1988; Prigatano et al., 2008). Seizures associated with HH are usually
refractory to standard anti-epilepsy drugs, but surgical treatment can be
effective (Mittal et al., 2013). Multiple clinical studies have demonstrated that HHs are intrinsically epileptogenic (Kuzniecky et al., 1997;
Munari et al., 1995). However, cellular and molecular mechanisms underlying epileptogenesis within HH lesions remain incompletely understood (Wu et al., 2015).
Gap junctions are cell-to-cell channel-forming structures formed by
specialized proteins (connexins) in the plasma membranes of adjacent
cells. They allow direct electrical coupling and chemical communication
between almost all cell types in the central nervous system. Many different connexin proteins have been identiﬁed; most are speciﬁc for different cell types in the brain, including neurons and glia (Nakase et al.,
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2004; Rozental et al., 2000). Connexin-36 (Cx36) is predominantly
expressed in gamma-aminobutyric acid-ergic (GABAergic) interneurons (Cruikshank et al., 2005; Sohl et al., 2005). In the rat, Cx36 shows
a high level of expression in the hypothalamus, including the mammillary bodies (Condorelli et al., 2000). Gap junctions play an important
role in locally synchronizing GABAergic neuron activity, including
action-potential ﬁring and sub-threshold changes in transmembrane
potential resulting from inhibitory and excitatory post-synaptic potentials (Cruikshank et al., 2005). Gap junctions contribute to oscillating
ﬁeld potentials and enable GABAergic entrainment of principal (projection) neuron behavior within normal networks (Sohl et al., 2005).
In view of these functional features, gap junctions likely contribute
to the pathogenesis of epilepsy, particularly with respect to enhancing
synchronous activity of neuronal subgroups within epileptic networks
(Carlen et al., 2000; Dudek et al., 1998; Traub et al., 2004). This concept
is supported by in vitro and in vivo epileptic animal models, in which
the pharmacological blockade of gap junctions signiﬁcantly reduces seizure occurrence (Carlen et al., 2000; Traub et al., 2004). Interictal epileptiform discharges (in the form of fast oscillations) can be abolished in
freshly resected human epileptic tissue slices with carbenoxolone, a
non-speciﬁc gap-junction blocker (Roopun et al., 2010). However, the
understanding of gap junctions in human epileptogenesis is still limited
and the potential for gap-junction blockers as therapeutic agents for
human epilepsy remains effectively unexplored.
We hypothesized that neuronal gap junctions have a mechanistic
role in synchronizing neuronal ﬁring and contributing to seizure onset
in human HH. We evaluated the role of gap junctions in epileptogenesis
using multiple experimental approaches including Western-blot, immunohistochemical staining, electron microscopy and electrophysiology in HH tissue surgically resected from patients with treatmentresistant gelastic seizures. We found that HH tissue expressed signiﬁcantly higher level of Cx36 and Cx43 compared to normal control hypothalamic tissue, and pharmacological block of gap junctions signiﬁcantly
reduced seizure-like discharges in HH slices.

2. Materials and Methods
2.1. Informed Consent
Written informed consent for use of post-surgical tissue for research
purposes was obtained under protocols approved by the institutional
review boards at Barrow Neurological Institute, St. Joseph's Hospital
and Medical Center, and Barrow Neurological Institute at Phoenix
Children's Hospital (Phoenix, Arizona).

2.2. Patient Proﬁle
Surgically resected HH tissue was obtained from 27 patients (15
males, 56%) treated between July 2003 and April 2013 (mean age at surgery, 10.3 years; range, 0.7–36.8 years). All patients had treatmentresistant epilepsy and a history of gelastic seizures. At the time of surgery, nine (33%) had only gelastic seizures, while 18 (67%) had multiple
seizure types, including complex partial seizures (Kim et al., 2009), generalized tonic-clonic (nine), myoclonic (two), atonic (two), and infantile spasms (one). Twenty-ﬁve patients (93%) had at least one seizure
per day, while two (7%) had at least one seizure per month. Intellectual
disability or developmental retardation (intelligence quotient or developmental quotient b 70) was present in 13 patients (48%) and prior history of central precocious puberty was present in nine (33%). None of
the patients in this cohort had identiﬁed genetic syndromes. Classiﬁcation of HH lesions according to the method of Delalande and Fohlen
(Delalande et al., 2003) showed eight Type I (30%), nine Type II (33%),
seven Type III (26%), and three Type IV (11%) lesions. Mean lesion volume was 2.7 cm3 (range, 0.2–14.8 cm3).
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2.3. Control Tissue
Normal human hypothalamic control tissues were obtained from
the U.S. National Institute of Child Health and Human Development
(NICHD) Brain and Tissue Bank for Developmental Disorders at the University of Maryland (Baltimore, MD).
2.4. Immunohistochemical Staining for Connexins in HH Tissue
HH tissue was sectioned into 4-μm slices. Tissue was deparafﬁnized
and antigen retrieval was performed using 10 mM of sodium citrate
buffer, washed with phosphate-buffered saline (PBS), blocked for 1 h
at room temperature in 4% normal serum, 4% bovine serum albumin
(BSA), and 0.4% Triton X in PBS. The tissue was incubated overnight at
4 °C with the primary antibody. Separate sections were stained for
Cx36 1:150 (Abcam, Cambridge, MA) and Cx43 1:3000 (Abcam), each
double-labeled with NeuN 1:500 (Millipore, Billerica, MA). Slides were
incubated with goat anti-rabbit conjugated Alexa 594 and goat antimouse conjugated Alexa 488 (Invitrogen, Carlsbad, CA) secondary antibodies for 2 h at room temperature.
2.5. Western-blot Analysis of Connexin Expression in HH Tissue
Tissue samples were sonicated in RIPA buffer (150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% Na deoxycholate, 50 mM Tris), and total protein was determined using BCA protein assays (Thermo-Scientiﬁc,
Waltham, MA). Experiments were performed on the XCell II Blot Module (Invitrogen). From each sample, 20 μg of protein was loaded into a
lane on a NuPage 4–12% Bis-Tris gel (Life Technologies, Carlsbad, CA),
transferred to 0.2-μm polyvinylidene diﬂuoride membrane (Bio-Rad,
Hercules, CA), and processed with a blocking solution of 3% BSA and
5% nonfat dry milk in 1× tris-buffered saline and Tween-20 (TBST). Rabbit anti-Cx36 (0.5 μl/ml; Invitrogen), rabbit anti-Cx43 (0.2 μl/ml;
Invitrogen), and mouse anti-tubulin (1:10,000; Sigma-Aldrich, St.
Louis, MO) were used as primary antibodies, and were visualized with
horseradish peroxidase-conjugated anti-rabbit antibody (1:10,000;
Invitrogen) or anti-mouse IgG antibody (1:10,000; Sigma-Aldrich). Signals were enhanced using enhanced chemiluminescence detection reagents (Thermo-Scientiﬁc) and detected on a BioSpectrum imaging
system (UVP, Upland, CA). Densities were quantiﬁed using VisionWorks
(UVP) and normalized relative to tubulin.
2.6. Electron Microscopy (EM) Analysis of Gap Junction Proﬁles in HH
Tissue
Tissue processing: Up to three pieces of tissue (1–3 mm in diameter)
were provided for ultrastructural examination, ﬁxed overnight in 3%
phosphate-buffered glutaraldehyde, post-ﬁxed for 2 h with 2%
phosphate-buffered osmium tetroxide, dehydrated with a series of
graded ethanols and propylene oxide, and embedded in epoxy resin
(LX-112, Ladd Research, Williston, VT). Thin tissue sections were cut
with a diamond knife (Diatome AG, Biel, Switzerland), mounted on
150-mesh copper grids (Ted Pella, Redding, CA), and stained with lead
citrate and uranyl acetate. Serial sections for three-dimensional reconstructions were mounted on polyvinyl formal-coated grids with a single
slot (1 × 2 mm).
Image processing: Sections were examined with a Philips CM100
equipped with a CompuStage (FEI Company, Hillsboro, OR). Images
were captured with an Orius SC1000 camera (Gatan, Pleasanton, CA).
2.7. Fresh HH Slice Preparation
Surgically resected HH slices were prepared based on our published
protocol (Wu et al., 2005). Brieﬂy, fresh HH-tissue sections obtained at
the time of surgery were immediately placed in ice-cold dissection solution (2–4 °C), which contained (in mM) 136.7 NaCl, 5 KCl, 0.1 NaH2PO4,
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9.84 N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES),
16.6 glucose, and 21.9 sucrose; the sections were continuously bubbled
with carbogen (95% O2/5% CO2; pH 7.4) during delivery from the operating room to the research laboratory. The tissue sections were quickly
sliced into several smaller pieces (250-μm thick for whole-cell patchclamp recording and 450–500-μm thick for ﬁeld recording) using a
Vibratome (Vibratome Company, St. Louis, MO) and were bubbled
with carbogen at 35 °C for 30 min in an incubation solution (in mM:
124 NaCl, 5 KCl, 24 NaHCO3, 1.3 MgSO4, 1.2 KH2PO4, 2.4 CaCl2, 10 glucose), and then further incubated at room temperature (22 ± 1 °C)
for at least 1 h.

Cx43. Fig. 1 demonstrates the results from triple immunohistochemical
staining, in which red indicated either Cx36 in left panel or Cx43 in right
panel, green indicated NeuN staining for neurons, and blue indicated
DAPI staining for all cell nucleus. Results showed that all HH sections
tested showed differences in the regional distribution of connexin
proteins—Cx36 showed more abundant staining intensity within neuron clusters, while Cx43 was more abundant within the neuron-poor region (as shown by co-labeling with NeuN, which stains all neurons, and
DAPI, which stains all nucleated cells including glia) (Fig. 1).

3.2. Enhanced Expression of Gap Junction Proteins in Human HH Tissue
2.8. Electrophysiological Recordings in Fresh HH Slices
Standard extracellular ﬁeld potential recordings were performed in
thick (450 μm) HH slices using borosilicate glass micropipettes ﬁlled
with 2 M NaCl. The recording temperature was set to 34 ± 1 °C. For
each HH slice, we scanned at least 16 recording sites (4 × 4) with
500-μm distance. The spontaneous seizure-like discharges were recorded using an Axoclamp-2B ampliﬁer (Axon Instruments, Inc., Union City,
CA).
To measure HH neuron action potential, whole-cell patch-clamp recording in current-clamp mode from HH slices (250 μm) was performed, and the pipette solution contained (in mM) 130 mM KMeSO4,
10 mM KCl, 10 mM HEPES/K-HEPES, 2 mM MgSO4, 0.5 mM EGTA, and
3 mM ATP; the pH was adjusted to 7.3 with KOH.
2.9. Statistics
All statistical experimental results are presented as mean ± SEM except the use of medians and quartiles to quantify Western blot data. The
Student's t-test (parametric data) or Mann Whitney U test (non-parametric data) was used to compare two groups; multiple comparisons
were performed using one-way analysis of variance (ANOVA), Chi
square test was used to compare cell numbers between two groups of
patch-clamp recordings with and without gap junction blocker. Statistical signiﬁcance was set at p b 0.05.
3. Results
3.1. Expression of Gap Junction Proteins in Human HH Tissue
To determine whether gap junction proteins are expressed in
human HH tissue, we performed immunohistochemical staining to explore expression of Cx36 (neuronal) and Cx43 (glial) connexin proteins
(eight patients for each). All HH tissues (100%) expressed Cx36 and

To determine if the expression of gap junction proteins is altered relative to adjacent control tissue, we performed Western-blot assays to
quantitatively compare Cx36 and Cx43 protein levels between human
HH tissue and age-matched human autopsy control tissue (mammillary
body) (eight subjects versus eight control specimens for each study).
Connexin levels were normalized to tubulin levels for all samples. Fig.
2A demonstrates a typical gel data from 3 control and 4 HH patients
(HH number is patient ID for research). Statistical analysis showed signiﬁcant increased expression (p b 0.05 by Mann Whitney U test for nonparametric data) of both Cx36 and Cx43 in epileptic HH tissue (n = 8
patients) versus normal controls (n = 8 cases) (Fig. 2B). Panel I shows
a striking co-localization of Cx36 within the cluster of small HH neurons
as indicated by green staining with NeuN (panel IB) and very little Cx36
immunoreactivity in regions without neurons (panel IA). In Panel II,
conversely, Cx43 co-localizes in regions of the tissue with many glia
and few neurons (panel IIC) with less expression within neuron clusters
(panel IID). Thus, the protein expression level of Cx36 (neuronal) gap
junction is higher in epileptic HH tissue relative to adjacent normal
hypothalamus.

3.3. Ultrastructural Evidence of Gap Junction Proﬁles between Small HH
Neurons
We used electron microscopy to detect the presence of gap-junction
proﬁles in HH sections, with particular attention to the phenotype of the
cellular pair contributing to the gap junction (seven cases). While
trilaminar gap-junction proﬁles were present, it was challenging to
make this visual determination in such a way that the phenotype of
both cells could be determined with complete certainty, as many such
proﬁles were indeterminate. In four of the seven HH cases (57%) studied, we found at least one trilaminar gap-junction proﬁle connecting adjacent small HH neurons (Fig. 3).

Fig. 1. A representative case showing immunohistochemistry for Cx36 (neuronal) and Cx43 (glial) proteins in surgically resected human HH tissue. Triple staining was applied: red for
antibodies to either Cx36 (panel I) or Cx43 (panel II), green for the antibody to NeuN (both panels), and blue for reactivity with DAPI (both panels). The scale bar in IID also applies to
IA, IB, and IIC.

J. Wu et al. / EBioMedicine 8 (2016) 96–102

99

neurons as round cells (soma diameter b 20 μm) with spontaneous action potential ﬁring, consistent with the expected phenotype (Wu et al.,
2005). We injected biocytin into the recorded neurons, followed by a
depolarizing protocol (repetitive application of depolarizing current of
30–50 pA into recorded neurons for 3–5 min), which promotes the
opening of gap junctions. In 23 small HH neurons tested (from 12 patients), 17 recorded neurons showed multiple adjacent biocytin labeled
neurons (neuron pairs) and 6 neurons showed single labeled neuron
(Fig. 4A–B). The average of labeled cell number per biocytin injection
was 2.6 ± 0.3. However, in the presence of the neuronal (Cx36) gapjunction blocker, meﬂoquine (10 μM), no labeling of adjacent neurons
(neuron pairs) was observed in 11 injected small HH neurons (from
six patients) (Fig. 4C–D). Statistical analysis of labeled neuronal numbers in the group without meﬂoquine vs. with meﬂoquine (2.6 ± 0.3
vs. 1) demonstrated signiﬁcant difference (Chi-square Test: Chisquare = 16.3 with 4 degrees of freedom, and p = 0.003). These results
are consistent with the presence of functional gap junctions that couple
small HH neurons.

3.5. Effects of Neuronal Gap-junction Blocker on Ictal/Interictal-like Discharges in HH Slices

Fig. 2. Boxplot of Western-blot study of connexin protein levels within HH tissue (HH)
versus human age-matched autopsy control mammillary body tissue (MAM). (A) A
typical gel data from 3 control and 4 HH patients (HH number is patient ID for research)
showed enhanced level of Cx36 in HH tissues compared to control tissues.
(B) Expression levels are normalized to tubulin expression. Expression of Cx36 levels
(left panel) in HH were signiﬁcantly higher than in MAM control tissue (p = 0.04;
Mann-Whitney) and expression of Cx43 (right) in HH was signiﬁcantly higher than in
MAM control tissue (p = 0.005; Mann-Whitney). Data are presented as follows: bar
within box = median, upper edge of box = third quartile, lower edge of box = ﬁrst
quartile, upper whisker = maximum, lower whisker = minimum, open circle = outlier
(N3× expected range of variation).

3.4. Functional Evidence for the Presence of Gap Junctions
To establish the presence of functional gap junctions between small
HH neurons, we performed whole-cell patch-clamp recordings in HH
slices. Under DIC-interfering microscope, we identiﬁed small HH

Results presented thus far support the premise that functional gap
junctions are highly expressed in human HH tissue. To explore the possible role of gap junctions in ictal/interictal genesis, we examined the effects of neuronal type gap-junction blocker, meﬂoquine on spontaneous
ictal/interictal-like discharges in HH slices using ﬁeld potential recordings because meﬂoquine is known as a relatively selective neuronal
(Cx36) gap-junction blocker (Juszczak et al., 2009). Fig. 5 shows results
from 8 HH tissue slices prepared from four patients with spontaneous
ictal/interictal-like discharges (Fig. 5Aa). Bath-application of 10 μM mefloquine for 20 min dramatically eliminated these spontaneous ictal/
interictal-like discharges (Fig. 5Ab). After washout for 10–30 min,
these spontaneous ictal/interictal-like discharges could be recovered
(Fig. 5A,c). In parallel experiments on HH tissue slices prepared from
the same patient (but not from the same HH slice), whole-cell patchclamp recordings showed that the spontaneous action potential ﬁring
of small HH neurons was not affected by 10 μM meﬂoquine (Fig. 5B),
suggesting that meﬂoquine blocks ictal/interictal-like discharges by
interrupted network synchronization, but not by blocking spontaneous
action potential ﬁring in individual small HH neurons. Statistical analysis from eight HH slices tested (from four patients) demonstrated a signiﬁcant reduction of bursting numbers (p b 0.001, paired t-test) and
amplitude (p b 0.001, paired t-test) by bath-perfusion of 10 μM meﬂoquine (Fig. 5C). These results suggest that pharmacological block of
neuronal gap junction eliminates ictal/interictal activity in human HH
slices.

Fig. 3. (A) Electron photomicrograph of two adjacent small HH neurons. The nuclei (N) are relatively large with a single dense nucleolus, surrounded by a relatively thin rim of cytoplasm,
deﬁning the cell body. These are the expected features for small HH neurons (as described by Beggs et al., 2008; Parvizi et al., 2011). Specialized non-synaptic junctions (possible gapjunction proﬁles; GJ) can be observed between the soma of these two neurons (see inset). (B) A gap junction proﬁle (arrow) with tri-laminar structure between neurites in close
proximity to a large axon terminal ﬁlled with synaptic vesicles. The inset shows greater detail of the gap junction. Our staining method shows that dense material connects adjacent
plasma membranes.
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Fig. 4. (A–B) Photomicrograph of an injected small HH neuron subsequent to whole-cell
patch-clamp microelectrode recording (WC patch). Filling the recorded cell with
biocytin has also ﬁlled multiple adjacent cells, likely other small HH neurons. (C–D)
Photomicrographs of two small HH neurons injected with biocytin after microelectrode
recording in the presence of meﬂoquine, a gap-junction blocker that is relatively speciﬁc
for neuronal gap junctions. In the presence of meﬂoquine, adjacent neurons were not
labeled.

3.6. Effects of Carbenoxolone on Ictal/interictal-like Discharges in HH Slices
We then tested the drug carbenoxolone, which is known to block
gap junctions in a non-speciﬁc manner and has been observed to reduce seizure activity in animal models (Jin et al., 2011). Figure 6Aa
showed a typical trace of spontaneous ictal/interictal-like discharges in a HH slice. Like meﬂoquine, carbenoxolone (10 or
100 μM) also dramatically eliminated these spontaneous ictal/
interictal-like discharges (Fig. 6Ab,c), which was partially reversible after washout for 10–30 min (Fig. 6Ad). Again, like meﬂoquine,
the carbenoxolone (100 μM) did not affect neuronal action potential
ﬁring in small HH neurons using patch-clamp recordings the HH
slices from the same HH patient (Fig. 6B). We observed the suppression of ictal/interictal-like discharges in a concentration-dependent
manner by examining the effect of carbenoxolone at three different
concentrations. Compared with baseline level, the bursting numbers were reduced to 81.5 ± 7.1%, 62.7 ± 12.6%, and 11.5 ± 7.4%
by 1 μM (n = 3 from 2 patients), 10 μM (n = 3 from 2 patients),
and 100 μM (n = 5 from 4 patients) carbenoxolone, respectively.
One-way ANOVA analysis indicated a highly signiﬁcant difference
of ictal/interictal-like discharges before and after carbenoxolone
perfusion (F = 36.48, p b 0.0001). Post Tukey's analysis showed
that 10 (p b 0.05) and 100 (p b 0.001), but not 1 μM (p N 0.05) of
carbenoxolone signiﬁcantly reduced seizure-burst frequency.
These results further suggest that the block of gap junction (but
not action potential ﬁring of individual small HH neurons) by gap
junction blocker (meﬂoquine or carbenoxolone) signiﬁcantly reduced ictal/interictal-like discharges in human HH tissues.

Fig. 5. Effects of neuronal-type gap-junction blocker on spontaneous ictal/interictal-like
discharges in HH slices. (Aa) Representative typical trace of spontaneous ictal/interictallike discharges of an HH slice (baseline). The bursting events are marked by horizontal
bars, and the bursting maximum amplitudes (Pmax) are also indicated by two horizontal
dashed lines. The lower trace (baseline, inset) shows an expanded bursting spike
activity (from a selected discharge period) over a time demonstrating a γ range (60 Hz)
spike-wave discharge. After bath perfusion of the neuronal-type gap-junction blocker,
meﬂoquine (10 μM for 10 min), the ictal/interictal-like discharges are reduced (Ab).
After washout of meﬂoquine for 20 min, the seizure-like discharges are reversed (Ac).
(B) Whole-cell patch-clamp recording represents a typical trace of spontaneous action
potential ﬁring of a small HH neuron from the HH slice collected from the same HH
patient shown in ﬁg. 5A and demonstrate no change of exposure of 10 μM meﬂoquine
for 10 min. (C) Statistical analysis from eight HH slices (from four patients) shows that
the neuronal-type gap-junction blocker signiﬁcantly reduces both seizure bursting ﬁring
numbers and amplitude. ***p b 0.001.

4. Discussion
Our results suggest that neuronal gap junctions between small HH
neurons play a critical role in enabling synchrony of ﬁring activity,
thereby contributing to seizure-like discharges in HH. These results
also suggest a potential strategy of using neuronal gap-junction blockers
as therapeutic drugs to control seizure activity in HH patients with
gelastic seizures.
How do these results contribute to the working model for
epileptogenesis in HH tissue? Two predominant neuron phenotypes reside within HH tissue (Coons et al., 2007). The majority (approximately
90%) of HH neurons are small, round, monopolar or bipolar cells with
local aspiny processes (Beggs et al., 2008; Coons et al., 2007; Kim do et
al., 2008). These neurons express glutamic acid decarboxylase and project to symmetrical synapses; therefore, they are likely to be GABAergic
interneurons (Beggs et al., 2008; Kim do et al., 2008; Wu et al., 2007; Wu
et al., 2005). Small HH neurons occur in clusters that vary in size and
abundance, but otherwise appear to be a universal feature of HH
microarchitecture (Coons et al., 2007). Conversely, large HH neurons
(approximately 10% of total) have a morphology consistent with
projection-type cells, including a pyramidal shape, abundant Nissl substance, and multiple processes that are more highly branched and more
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Fig. 6. (A) The microelectrode ﬁeld recording of freshly resected, perfused HH tissue (slice
thickness 450 μm) demonstrates spontaneous ictal/interictal-like discharges with the
repetitive bursting (1–2 Hz) (baseline, Aa). The lower trace (baseline, inset) shows an
expanded bursting spike activity (from a selected discharge period) over a time
demonstrating a γ range (60 Hz) spike-wave discharge. Field recording from the same
tissue slice after bath application of 10 or 100 μM carbenoxolone (Carb) for 10 min both
show a suppression of seizure-like discharges (A,b,c). The ﬁeld recording from the same
tissue slice after wash-out of carbenoxolone for 35 min shows partial recovery of the
seizure-like discharges seen during the pre-application baseline (Ad). (B) Whole-cell
patch-clamp recording in current-clamp mode from the same patient HH slice (different
HH slices from ﬁeld recording) demonstrates no detectable change of action potential
ﬁring of a small HH neuron observed before, during, and after 100 μM carbenoxolone
perfusion.

likely to be spiny (Beggs et al., 2008; Coons et al., 2007; Kim do et al.,
2008).
Small HH neurons have spontaneous pacemaker-like ﬁring resulting
from intrinsic membrane properties (Kim do et al., 2008; Wu et al.,
2007; Wu et al., 2008; Wu et al., 2005). Most large HH neurons exhibit
a functionally immature response to GABA exposure, with depolarization and increased ﬁring, resulting from reversal of the transmembrane
chloride potential (Kim do et al., 2008; Kim et al., 2009; Wu et al., 2008).
Taken together, these ﬁndings suggest a cellular model in which clusters
of spontaneously ﬁring interneurons paradoxically excite projection
neurons in a functional network (Wu et al., 2015). There is indirect evidence for network activity within HH neuron clusters with microelectrode ﬁeld recordings of high-frequency oscillations in perfused HH
tissue slices (Simeone et al., 2011) and highly synchronous ﬁring of single units with microelectrode ﬁeld recordings in situ (prior to surgical
resection) (Steinmetz et al., 2013).
Two basic cellular mechanisms are required for seizure
activity—imbalance between excitatory and inhibitory inﬂuences with
net excitation of the cellular network and enhanced synchrony of neuronal ﬁring (Avoli et al., 2005). We hypothesized that synchrony of ﬁring activity within HH tissue is mediated in part by non-synaptic
mechanisms, speciﬁcally gap junctions, which are capable of electrically
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linking adjacent neurons. In this study, we tested our hypothesis using
multiple experimental approaches. The electron microscopy demonstrated an evidence of existence of gap junctions between small-sized
GABA neurons in HH slices. The functional gap junctions between
GABA neurons in HH slices were supported by microinjection of small
HH neurons with biocytin via recording electrode under patch-clamp
recording conditions demonstrates dye-coupling of adjacent neurons.
Although the gap junctions are known to express in normal hypothalamic tissues (Condorelli et al., 2000), our Western-blot data showed a
signiﬁcant increase in expression level of Cx36 and Cx43 in HH tissue
compared to normal control adjacent mammillary body tissue. These
data suggest a possibility that enhanced gap junction proteins may promote GABA neuron synchronization and form the seizure-like discharges in HH lesion. This idea was further supported by
electrophysiological experiments, in which, pharmacological blockade
of gap junctions abolishes seizure-like discharges in freshly resected,
perfused HH tissue slices without suppressing spontaneous single-unit
ﬁring activity. Our ﬁndings demonstrate the presence of neuronal gap
junctions and suggest that gap junctions have a mechanistic role in generating seizure activity in HH tissue.
We acknowledge technical limitations to this study. We have utilized age-matched human autopsy hypothalamic tissue (mammillary
body) as a control tissue for Western blots. We recommend mammillary
body for control studies as this nucleus is immediately adjacent to all
HH lesions associated with epilepsy (Parvizi et al., 2011) and it is readily
identiﬁable in autopsy specimens. However, the embryological relationship between mammillary body and HH is unexplored and the cellular
phenotypes are likely dissimilar. The increase of both Cx36 and Cx43
may relate to immature properties of HH tissue, as reﬂected by functional immaturity of large HH neurons with paradoxical excitation in response to GABA ligands. For our electrophysiological study with gap
junction blockers, all comparisons were set up in the same recorded
slice (or cell) before during and after gap junction blocker exposure. Another limitation is that we were not able to do in vivo study directly in
HH patients in this paper. However, the intrinsic epileptic feature of
HH allows us to test the role of gap junctions in epileptogenesis using
HH slices, which provides signiﬁcant insights into understanding of
the impact of gap junctions in gelastic seizure genesis.
While providing new insights into the cellular mechanisms responsible for gelastic seizures arising in HH tissue, these results also suggest a
novel approach to treatment, prompting research to evaluate the safety
and efﬁcacy of gap-junction blockers in HH patients. Gap-junction
blockers are currently under investigation in people with migraines;
the proposed mechanism in those studies is to attenuate or abolish
cortical-spreading depression (Silberstein, 2009). Clear evidence for efﬁcacy is thus far lacking, but gap-junction blockers appear to be safe and
well tolerated. Based upon the ﬁndings reported here, we propose that
gap-junction blockers are worthy of further investigation for treating
seizures associated with HH and other types of epilepsy.
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